| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-12 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-08 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |